Nu Skin Enterprises, Inc. (NYSE:NUS) CEO Acquires $202,500.00 in Stock
Nu Skin Enterprises, Inc. (NYSE:NUS) CEO Ritch N. Wood purchased 10,000 shares of the business’s stock in a transaction on Friday, March 20th. The stock was bought at an average cost of $20.25 per share, for a total transaction of $202,500.00. Following the purchase, the chief executive officer now owns 153,192 shares of the company’s stock, valued at approximately $3,102,138. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website.
Shares of Nu Skin Enterprises stock opened at $21.60 on Thursday. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.07 and a quick ratio of 1.30. Nu Skin Enterprises, Inc. has a one year low of $12.31 and a one year high of $64.90. The stock has a market capitalization of $1.15 billion, a P/E ratio of 6.95, a price-to-earnings-growth ratio of 5.09 and a beta of 0.79. The business’s 50 day simple moving average is $26.20 and its two-hundred day simple moving average is $37.09.
Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings results on Wednesday, February 12th. The company reported $0.72 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.72. The company had revenue of $583.36 million for the quarter, compared to analysts’ expectations of $582.49 million. Nu Skin Enterprises had a return on equity of 20.62% and a net margin of 7.17%. The firm’s revenue for the quarter was down 14.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.05 earnings per share. Sell-side analysts expect that Nu Skin Enterprises, Inc. will post 2.17 earnings per share for the current fiscal year.
Several large investors have recently made changes to their positions in NUS. FNY Investment Advisers LLC purchased a new stake in Nu Skin Enterprises in the fourth quarter worth about $40,000. Voloridge Investment Management LLC lifted its stake in shares of Nu Skin Enterprises by 499.4% in the 3rd quarter. Voloridge Investment Management LLC now owns 38,755 shares of the company’s stock valued at $1,648,000 after purchasing an additional 32,289 shares during the last quarter. Prudential Financial Inc. lifted its stake in shares of Nu Skin Enterprises by 7.8% in the 4th quarter. Prudential Financial Inc. now owns 529,366 shares of the company’s stock valued at $21,693,000 after purchasing an additional 38,200 shares during the last quarter. Mackay Shields LLC lifted its stake in shares of Nu Skin Enterprises by 68.2% in the 4th quarter. Mackay Shields LLC now owns 321,268 shares of the company’s stock valued at $13,166,000 after purchasing an additional 130,281 shares during the last quarter. Finally, MUFG Securities EMEA plc lifted its stake in shares of Nu Skin Enterprises by 57.4% in the 4th quarter. MUFG Securities EMEA plc now owns 128,855 shares of the company’s stock valued at $5,280,000 after purchasing an additional 47,000 shares during the last quarter. 74.19% of the stock is currently owned by hedge funds and other institutional investors.
NUS has been the topic of a number of recent research reports. Bank of America lowered their price objective on shares of Nu Skin Enterprises from $40.00 to $30.00 and set an “underperform” rating on the stock in a report on Thursday, February 13th. Deutsche Bank downgraded shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating and decreased their price objective for the company from $40.00 to $28.00 in a report on Monday, March 9th. DA Davidson reiterated an “in-line” rating and issued a $35.00 price objective on shares of Nu Skin Enterprises in a report on Thursday, February 13th. They noted that the move was a valuation call. Finally, Citigroup reduced their target price on shares of Nu Skin Enterprises from $43.00 to $33.00 and set a “neutral” rating for the company in a research report on Friday, February 14th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and one has assigned a buy rating to the company. Nu Skin Enterprises presently has an average rating of “Hold” and a consensus target price of $40.63.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Further Reading: What is a stock portfolio tracker?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.